Summary
Thermo Fisher Scientific Inc. (TMO) reported strong revenue growth of 12% for the second quarter of 2004, reaching $525.3 million, and a 10.6% increase to $1.05 billion for the six-month period ended July 3, 2004. This growth was driven by increased demand across its Life and Laboratory Sciences and Measurement and Control segments, with favorable currency translations also contributing. The company successfully executed strategic acquisitions, including US Counseling Services, Inc. (USCS) and Jouan SA, which are integrating well and contributing to revenue growth, though impacting profit margins in the short term due to amortization of intangible assets. Operationally, the company saw an improvement in operating income to $59.0 million for the quarter, with an improved operating margin of 11.2%, largely due to lower restructuring costs compared to the prior year. Net income increased significantly to $91.1 million for the quarter. The company also announced the completion of the sale of its Optical Technologies segment, Spectra-Physics, on July 16, 2004, for $300 million, which is expected to result in an additional gain in the third quarter. This strategic divestiture allows TMO to focus on its core businesses. Liquidity remains strong, with $371.8 million in cash and investments as of July 3, 2004, supplemented by proceeds from the Spectra-Physics sale and available credit facilities, providing confidence in meeting capital requirements for at least the next 24 months. The company also announced an additional $100 million share repurchase authorization, indicating a commitment to returning value to shareholders.
Key Highlights
- 1Revenues increased by 12% to $525.3 million in Q2 2004, and by 10.6% to $1.05 billion for the first six months of 2004, driven by demand and acquisitions.
- 2Operating income improved to $59.0 million in Q2 2004, with an operating margin of 11.2%, benefiting from lower restructuring costs compared to the prior year.
- 3Net income for the quarter surged to $91.1 million, a significant increase from $53.1 million in the prior year's second quarter.
- 4The company completed the sale of its Optical Technologies segment (Spectra-Physics) on July 16, 2004, for $300 million, which will be recognized in Q3 earnings.
- 5Strategic acquisitions, including USCS and Jouan SA, are contributing to revenue growth, though initial amortization of acquired intangibles impacted profit margins.
- 6Cash flow from operations was robust at $105.0 million for the first six months of 2004, indicating strong operational performance.
- 7The company possesses strong liquidity with $371.8 million in cash and investments as of July 3, 2004, and substantial borrowing capacity.